The Correlation Between Sevoflurane and qNOX

China International Neuroscience Institution58 enrolled

Overview

This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.

This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the analgesia effect of the sevoflurane. And test the correlation between the sevoflurane and NOX index.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Analgesic Adverse Reaction Nociceptive Pain Inhalation; Vapor

Interventions

nociception index qNOXDEVICE

non-invasive, real time, monitoring for nociception stimulation

Eligibility

Sex: ALLMin age: 25 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Elective thoracoscope surgery patients 2. Age ranging from 25 to 85 years 3. American Society of Anesthesiologists (ASA) Physical Status score of 2 to 4 4. a body mass index (BMI) ranging from 18.5 to 40 kg/m2. Exclusion Criteria: 1. Clinical diagnosis of Alzheimer's Disease 2. implanted pacemaker 3. Clinical diagnosis of psychiatric diseases 4. Clinical diagnosis of epilepsy 5. Clinical diagnosis of autonomic nervous system disorders which might affect the EEG

Locations (1)

Bei Liu

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

The sevoflurane application correlated with the qNOX index

The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application

Time frame: through study completion, an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.